Ami Chitalia, M.D.
NPI 1083939102ActiveIndividual· Internal Medicine, Hematology & Oncology· Washington, DC
Internal Medicine, Hematology & Oncology (M.D.) in Washington, District of Columbia, trained at Tufts University School of Medicine (class of 2010). Their prescriptions cost Medicare Part D more than their services did: $489,351 for 612 claims, against $83,364 paid for services in 2024. Astrazeneca Pharmaceuticals LP was the largest of 18 companies reporting payments in 2025, $4,076 in all, mostly consulting fees.
Overview
| NPI | 1083939102 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | M.D. |
| Sole proprietor | Yes |
| NPI issued | Mar 31, 2010 |
| Last updated in NPPES | Apr 9, 2014 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine, Hematology & Oncology Primary | 207RH0003X | MD040307 | DC |
| Student in an Organized Health Care Education/Training Program | 390200000X | — | — |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Nov 10, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 11, 2026 | No match | — |
| New York OMIG · Nov 11, 2026 | No match | — |
| Ohio Medicaid · Nov 11, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 11, 2026 | No match | — |
| Washington HCA · Nov 11, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Hematology/Oncology (DC) |
|---|---|
| Accepts assignment | Yes (participating) |
Medicare services in 2024
| Medicare patients | 294 |
|---|---|
| Services billed | 1,031 across 11 procedure codes |
| Paid by Medicare | $83,364 |
Part D prescriptions in 2024
| Prescriptions (claims) | 612 · 1,258 30-day fills |
|---|---|
| Patients | 182 |
| Total drug cost | $489,351 |
| Generic share | 93% of claims |
Education and affiliations
| Medical school | Tufts University School of Medicine |
|---|---|
| Graduation year | 2010 |
| Medicare specialty | Hematology/Oncology |
| Secondary specialties | Internal Medicine, Medical Oncology |
| Telehealth | Offers telehealth |
Medical group
- Medstar Medical Group II LLCWashington, DC · 3,767 clinicians
Hospital affiliation
- Medstar Washington Hospital CenterWashington, DC
Industry payments (Open Payments)
- 2025$4,076 · 38 payments from 18 companies
- 2024$2,017 · 34 payments from 18 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,835 | 3 |
| Gilead Sciences, Inc. | $566.59 | 6 |
| Novartis Pharmaceuticals Corporation | $118.34 | 5 |
| Stemline Therapeutics Inc. | $85.02 | 3 |
| E.R. Squibb & Sons, L.L.C. | $71.74 | 2 |
What the 2025 payments were for
- Consulting Fee$3,130 · 2 payments
- Food and Beverage$946.15 · 36 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other hematologist-oncologists in Washington
- 1003985367
- 1154766533
- 1164414751
- 1164431748
- 1184794414
- 1194084053
- 1215223839
- 1235552290
- 1245726371
- 1275723199
- 1275896318
- 1316380264
All 90 hematologist-oncologists in Washington · All hematologist-oncologists in District of Columbia